Gabapentin Requires Dose Adjustment; Duloxetine and Quetiapine Require Caution; OxyNEO (Oxycodone) Requires Caution
Of the medications listed, gabapentin definitively requires dose adjustment based on renal function, while duloxetine and oxycodone should be used with caution and reduced doses in renal impairment; quetiapine does not require routine dose adjustment.
Gabapentin - REQUIRES DOSE ADJUSTMENT
Gabapentin is primarily renally excreted unchanged and absolutely requires dose adjustment based on creatinine clearance 1, 2. This is supported by both consensus guidelines and FDA labeling:
- Expert consensus guidelines specifically identify gabapentin as requiring dose reduction or interval extension with renal impairment 1
- FDA labeling confirms that gabapentin elimination half-life increases from 6.5 hours (CrCl >60 mL/min) to 52 hours (CrCl <30 mL/min) 2
- Plasma clearance decreases from approximately 190 mL/min to 20 mL/min as renal function declines 2
- A real-world case demonstrated serious harm (fall with hip fracture) when gabapentin was prescribed at 300 mg three times daily without renal dose adjustment in a dialysis patient 3
Clinical pitfall: Gabapentin toxicity can manifest as sedation, dizziness, and falls—particularly dangerous in older adults. The medication is not metabolized, so hepatic function is irrelevant; renal clearance is the sole elimination pathway 2, 4, 5.
Duloxetine - USE WITH CAUTION
Duloxetine requires caution and appears on lists of medications requiring dose adjustment in renal impairment 6. A 2025 study identified duloxetine as one of the most common medications prescribed at doses too high for renal function in hospice patients 6. While not primarily renally cleared like gabapentin, duloxetine and its metabolites have renal elimination components that warrant dose reduction or avoidance in moderate to severe renal impairment.
Quetiapine - NO ROUTINE ADJUSTMENT NEEDED
Quetiapine is primarily hepatically metabolized and does not appear on consensus lists of medications requiring renal dose adjustment 1. Standard dosing can typically be maintained in renal impairment, though general caution is warranted in elderly patients or those with multiple comorbidities.
OxyNEO (Oxycodone/Naloxone) - USE WITH CAUTION
Oxycodone should be used with caution and reduced doses in renal impairment 7, 8. The FDA label states that in end-stage renal impairment, mean elimination half-life is prolonged due to increased volume of distribution and reduced clearance 7.
Key considerations:
- While oxycodone itself may be used cautiously with dose reduction 8, 9, it is not as problematic as morphine or codeine
- Research indicates oxycodone requires "caution and reduced doses" in renal failure 8
- The combination product (OxyNEO contains naloxone) adds complexity, though the primary concern remains oxycodone accumulation
- Avoid morphine, codeine, and pethidine entirely in significant renal impairment due to toxic metabolite accumulation 8, 10, 9
Clinical algorithm: Calculate creatinine clearance for all four medications. For gabapentin, mandatory dose adjustment per renal function tables. For duloxetine and oxycodone, reduce dose by 25-50% if CrCl <30-50 mL/min and monitor closely for adverse effects. Quetiapine requires no specific renal adjustment but monitor for sedation in elderly patients.